aluates Reports

$ 0.0

Automative

Global Oral Insulin Market Research Report 2025

Published Date: February 2025

Report Code: QYRE-Auto-17T10544

Global Oral Insulin Market Research Report 2022

BUY CHAPTERS

Global Oral Insulin Market Research Report 2025

Code: QYRE-Auto-17T10544

Report

February 2025

Pages:79

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Novo Nordisk

Oramed Pharmaceuticals

VTV Therapeutics

Diabetology

Generex Biotechnology

Nektar Therapeutics

Coromed

Oral Insulin Market Size

The global market for Oral Insulin was valued at US$ 592 million in the year 2024 and is projected to reach a revised size of US$ 863 million by 2031, growing at a CAGR of 5.6% during the forecast period.

Oral Insulin Market

The oral delivery of drugs is considered as the most acceptable and convenient route of drug administration especially for chronic diseased conditions like diabetes. The treatment with oral insulin offers several advantages, such as higher patient compliance; rapid hepatic insulinization, and avoidance of peripheral hyperinsulinemia and other adverse effects such as possible hypoglycemia and weight gain.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Oral Insulin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Insulin.

The Oral Insulin market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oral Insulin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Oral Insulin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Oral Insulin Market Report

Report Metric	Details
Report Name	Oral Insulin Market
Accounted market size in year	US$ 592 million
Forecasted market size in 2031	US$ 863 million
CAGR	5.6%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Type 1 Diabetes Type 2 Diabetes
Segment by Application	Female Male
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Novo Nordisk, Oramed Pharmaceuticals, vTv Therapeutics, Diabetology, Generex Biotechnology, Coromed, Nektar Therapeutics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oral Insulin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Oral Insulin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Oral Insulin Market growing?

Ans: The Oral Insulin Market witnessing a CAGR of 5.6% during the forecast period 2025-2031.

What is the Oral Insulin Market size in 2031?

Ans: The Oral Insulin Market size in 2031 will be US$ 863 million.

Who are the main players in the Oral Insulin Market report?

Ans: The main players in the Oral Insulin Market are Novo Nordisk, Oramed Pharmaceuticals, vTv Therapeutics, Diabetology, Generex Biotechnology, Coromed, Nektar Therapeutics

What are the Application segmentation covered in the Oral Insulin Market report?

Ans: The Applications covered in the Oral Insulin Market report are Female, Male

What are the Type segmentation covered in the Oral Insulin Market report?

Ans: The Types covered in the Oral Insulin Market report are Type 1 Diabetes, Type 2 Diabetes

Recommended Reports

Oral Diabetes Drugs

Broader Oral Drugs

Diabetes Therapies & Devices

1 Oral Insulin Market Overview

1.1 Product Definition

1.2 Oral Insulin by Type

1.2.1 Global Oral Insulin Market Value Comparison by Type (2024 VS 2031)

1.2.2 Type 1 Diabetes

1.2.3 Type 2 Diabetes

1.3 Oral Insulin by Application

1.3.1 Global Oral Insulin Market Value by Application (2024 VS 2031)

1.3.2 Female

1.3.3 Male

1.4 Global Oral Insulin Market Size Estimates and Forecasts

1.4.1 Global Oral Insulin Revenue 2020-2031

1.4.2 Global Oral Insulin Sales 2020-2031

1.4.3 Global Oral Insulin Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Oral Insulin Market Competition by Manufacturers

2.1 Global Oral Insulin Sales Market Share by Manufacturers (2020-2025)

2.2 Global Oral Insulin Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Oral Insulin Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Oral Insulin, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Oral Insulin, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Oral Insulin, Product Type & Application

2.7 Global Key Manufacturers of Oral Insulin, Date of Enter into This Industry

2.8 Global Oral Insulin Market Competitive Situation and Trends

2.8.1 Global Oral Insulin Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Oral Insulin Players Market Share by Revenue

2.8.3 Global Oral Insulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Oral Insulin Market Scenario by Region

3.1 Global Oral Insulin Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Oral Insulin Sales by Region: 2020-2031

3.2.1 Global Oral Insulin Sales by Region: 2020-2025

3.2.2 Global Oral Insulin Sales by Region: 2026-2031

3.3 Global Oral Insulin Revenue by Region: 2020-2031

3.3.1 Global Oral Insulin Revenue by Region: 2020-2025

3.3.2 Global Oral Insulin Revenue by Region: 2026-2031

3.4 North America Oral Insulin Market Facts & Figures by Country

3.4.1 North America Oral Insulin Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Oral Insulin Sales by Country (2020-2031)

3.4.3 North America Oral Insulin Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Oral Insulin Market Facts & Figures by Country

3.5.1 Europe Oral Insulin Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Oral Insulin Sales by Country (2020-2031)

3.5.3 Europe Oral Insulin Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Oral Insulin Market Facts & Figures by Region

3.6.1 Asia Pacific Oral Insulin Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Oral Insulin Sales by Region (2020-2031)

3.6.3 Asia Pacific Oral Insulin Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Oral Insulin Market Facts & Figures by Country

3.7.1 Latin America Oral Insulin Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Oral Insulin Sales by Country (2020-2031)

3.7.3 Latin America Oral Insulin Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Oral Insulin Market Facts & Figures by Country

3.8.1 Middle East and Africa Oral Insulin Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Oral Insulin Sales by Country (2020-2031)

3.8.3 Middle East and Africa Oral Insulin Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Oral Insulin Sales by Type (2020-2031)

4.1.1 Global Oral Insulin Sales by Type (2020-2025)

4.1.2 Global Oral Insulin Sales by Type (2026-2031)

4.1.3 Global Oral Insulin Sales Market Share by Type (2020-2031)

4.2 Global Oral Insulin Revenue by Type (2020-2031)

4.2.1 Global Oral Insulin Revenue by Type (2020-2025)

4.2.2 Global Oral Insulin Revenue by Type (2026-2031)

4.2.3 Global Oral Insulin Revenue Market Share by Type (2020-2031)

4.3 Global Oral Insulin Price by Type (2020-2031)

5 Segment by Application

5.1 Global Oral Insulin Sales by Application (2020-2031)

5.1.1 Global Oral Insulin Sales by Application (2020-2025)

5.1.2 Global Oral Insulin Sales by Application (2026-2031)

5.1.3 Global Oral Insulin Sales Market Share by Application (2020-2031)

5.2 Global Oral Insulin Revenue by Application (2020-2031)

5.2.1 Global Oral Insulin Revenue by Application (2020-2025)

5.2.2 Global Oral Insulin Revenue by Application (2026-2031)

5.2.3 Global Oral Insulin Revenue Market Share by Application (2020-2031)

5.3 Global Oral Insulin Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Novo Nordisk

6.1.1 Novo Nordisk Company Information

6.1.2 Novo Nordisk Description and Business Overview

6.1.3 Novo Nordisk Oral Insulin Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Novo Nordisk Oral Insulin Product Portfolio

6.1.5 Novo Nordisk Recent Developments/Updates

6.2 Oramed Pharmaceuticals

6.2.1 Oramed Pharmaceuticals Company Information

6.2.2 Oramed Pharmaceuticals Description and Business Overview

6.2.3 Oramed Pharmaceuticals Oral Insulin Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Oramed Pharmaceuticals Oral Insulin Product Portfolio

6.2.5 Oramed Pharmaceuticals Recent Developments/Updates

6.3 vTv Therapeutics

6.3.1 vTv Therapeutics Company Information

6.3.2 vTv Therapeutics Description and Business Overview

6.3.3 vTv Therapeutics Oral Insulin Sales, Revenue and Gross Margin (2020-2025)

6.3.4 vTv Therapeutics Oral Insulin Product Portfolio

6.3.5 vTv Therapeutics Recent Developments/Updates

6.4 Diabetology

6.4.1 Diabetology Company Information

6.4.2 Diabetology Description and Business Overview

6.4.3 Diabetology Oral Insulin Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Diabetology Oral Insulin Product Portfolio

6.4.5 Diabetology Recent Developments/Updates

6.5 Generex Biotechnology

6.5.1 Generex Biotechnology Company Information

6.5.2 Generex Biotechnology Description and Business Overview

6.5.3 Generex Biotechnology Oral Insulin Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Generex Biotechnology Oral Insulin Product Portfolio

6.5.5 Generex Biotechnology Recent Developments/Updates

6.6 Coromed

6.6.1 Coromed Company Information

6.6.2 Coromed Description and Business Overview

6.6.3 Coromed Oral Insulin Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Coromed Oral Insulin Product Portfolio

6.6.5 Coromed Recent Developments/Updates

6.7 Nektar Therapeutics

6.7.1 Nektar Therapeutics Company Information

6.7.2 Nektar Therapeutics Description and Business Overview

6.7.3 Nektar Therapeutics Oral Insulin Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Nektar Therapeutics Oral Insulin Product Portfolio

6.7.5 Nektar Therapeutics Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Oral Insulin Industry Chain Analysis

7.2 Oral Insulin Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Oral Insulin Production Mode & Process Analysis

7.4 Oral Insulin Sales and Marketing

7.4.1 Oral Insulin Sales Channels

7.4.2 Oral Insulin Distributors

7.5 Oral Insulin Customer Analysis

8 Oral Insulin Market Dynamics

8.1 Oral Insulin Industry Trends

8.2 Oral Insulin Market Drivers

8.3 Oral Insulin Market Challenges

8.4 Oral Insulin Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Novo Nordisk

Oramed Pharmaceuticals

VTV Therapeutics

Diabetology

Generex Biotechnology

Nektar Therapeutics

Coromed

List of Tables

Table 1. Global Oral Insulin Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Oral Insulin Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Oral Insulin Market Competitive Situation by Manufacturers in 2024

Table 4. Global Oral Insulin Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Oral Insulin Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Oral Insulin Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Oral Insulin Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Oral Insulin Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Oral Insulin, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Oral Insulin, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Oral Insulin, Product Type & Application

Table 12. Global Key Manufacturers of Oral Insulin, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Oral Insulin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Insulin as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Oral Insulin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Oral Insulin Sales by Region (2020-2025) & (K Units)

Table 18. Global Oral Insulin Sales Market Share by Region (2020-2025)

Table 19. Global Oral Insulin Sales by Region (2026-2031) & (K Units)

Table 20. Global Oral Insulin Sales Market Share by Region (2026-2031)

Table 21. Global Oral Insulin Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Oral Insulin Revenue Market Share by Region (2020-2025)

Table 23. Global Oral Insulin Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Oral Insulin Revenue Market Share by Region (2026-2031)

Table 25. North America Oral Insulin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Oral Insulin Sales by Country (2020-2025) & (K Units)

Table 27. North America Oral Insulin Sales by Country (2026-2031) & (K Units)

Table 28. North America Oral Insulin Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Oral Insulin Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Oral Insulin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Oral Insulin Sales by Country (2020-2025) & (K Units)

Table 32. Europe Oral Insulin Sales by Country (2026-2031) & (K Units)

Table 33. Europe Oral Insulin Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Oral Insulin Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Oral Insulin Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Oral Insulin Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Oral Insulin Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Oral Insulin Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Oral Insulin Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Oral Insulin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Oral Insulin Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Oral Insulin Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Oral Insulin Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Oral Insulin Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Oral Insulin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Oral Insulin Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Oral Insulin Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Oral Insulin Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Oral Insulin Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Oral Insulin Sales (K Units) by Type (2020-2025)

Table 51. Global Oral Insulin Sales (K Units) by Type (2026-2031)

Table 52. Global Oral Insulin Sales Market Share by Type (2020-2025)

Table 53. Global Oral Insulin Sales Market Share by Type (2026-2031)

Table 54. Global Oral Insulin Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Oral Insulin Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Oral Insulin Revenue Market Share by Type (2020-2025)

Table 57. Global Oral Insulin Revenue Market Share by Type (2026-2031)

Table 58. Global Oral Insulin Price (US$/Unit) by Type (2020-2025)

Table 59. Global Oral Insulin Price (US$/Unit) by Type (2026-2031)

Table 60. Global Oral Insulin Sales (K Units) by Application (2020-2025)

Table 61. Global Oral Insulin Sales (K Units) by Application (2026-2031)

Table 62. Global Oral Insulin Sales Market Share by Application (2020-2025)

Table 63. Global Oral Insulin Sales Market Share by Application (2026-2031)

Table 64. Global Oral Insulin Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Oral Insulin Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Oral Insulin Revenue Market Share by Application (2020-2025)

Table 67. Global Oral Insulin Revenue Market Share by Application (2026-2031)

Table 68. Global Oral Insulin Price (US$/Unit) by Application (2020-2025)

Table 69. Global Oral Insulin Price (US$/Unit) by Application (2026-2031)

Table 70. Novo Nordisk Company Information

Table 71. Novo Nordisk Description and Business Overview

Table 72. Novo Nordisk Oral Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Novo Nordisk Oral Insulin Product

Table 74. Novo Nordisk Recent Developments/Updates

Table 75. Oramed Pharmaceuticals Company Information

Table 76. Oramed Pharmaceuticals Description and Business Overview

Table 77. Oramed Pharmaceuticals Oral Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Oramed Pharmaceuticals Oral Insulin Product

Table 79. Oramed Pharmaceuticals Recent Developments/Updates

Table 80. vTv Therapeutics Company Information

Table 81. vTv Therapeutics Description and Business Overview

Table 82. vTv Therapeutics Oral Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. vTv Therapeutics Oral Insulin Product

Table 84. vTv Therapeutics Recent Developments/Updates

Table 85. Diabetology Company Information

Table 86. Diabetology Description and Business Overview

Table 87. Diabetology Oral Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Diabetology Oral Insulin Product

Table 89. Diabetology Recent Developments/Updates

Table 90. Generex Biotechnology Company Information

Table 91. Generex Biotechnology Description and Business Overview

Table 92. Generex Biotechnology Oral Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Generex Biotechnology Oral Insulin Product

Table 94. Generex Biotechnology Recent Developments/Updates

Table 95. Coromed Company Information

Table 96. Coromed Description and Business Overview

Table 97. Coromed Oral Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Coromed Oral Insulin Product

Table 99. Coromed Recent Developments/Updates

Table 100. Nektar Therapeutics Company Information

Table 101. Nektar Therapeutics Description and Business Overview

Table 102. Nektar Therapeutics Oral Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Nektar Therapeutics Oral Insulin Product

Table 104. Nektar Therapeutics Recent Developments/Updates

Table 105. Key Raw Materials Lists

Table 106. Raw Materials Key Suppliers Lists

Table 107. Oral Insulin Distributors List

Table 108. Oral Insulin Customers List

Table 109. Oral Insulin Market Trends

Table 110. Oral Insulin Market Drivers

Table 111. Oral Insulin Market Challenges

Table 112. Oral Insulin Market Restraints

Table 113. Research Programs/Design for This Report

Table 114. Key Data Information from Secondary Sources

Table 115. Key Data Information from Primary Sources

Table 116. Authors List of This Report

List of Figures

Figure 1. Product Picture of Oral Insulin

Figure 2. Global Oral Insulin Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Oral Insulin Market Share by Type: 2024 & 2031

Figure 4. Type 1 Diabetes Product Picture

Figure 5. Type 2 Diabetes Product Picture

Figure 6. Global Oral Insulin Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Oral Insulin Market Share by Application: 2024 & 2031

Figure 8. Female

Figure 9. Male

Figure 10. Global Oral Insulin Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 11. Global Oral Insulin Market Size (2020-2031) & (US$ Million)

Figure 12. Global Oral Insulin Sales (2020-2031) & (K Units)

Figure 13. Global Oral Insulin Average Price (US$/Unit) & (2020-2031)

Figure 14. Oral Insulin Report Years Considered

Figure 15. Oral Insulin Sales Share by Manufacturers in 2024

Figure 16. Global Oral Insulin Revenue Share by Manufacturers in 2024

Figure 17. Global 5 and 10 Largest Oral Insulin Players: Market Share by Revenue in Oral Insulin in 2024

Figure 18. Oral Insulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 19. Global Oral Insulin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 20. North America Oral Insulin Sales Market Share by Country (2020-2031)

Figure 21. North America Oral Insulin Revenue Market Share by Country (2020-2031)

Figure 22. U.S. Oral Insulin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 23. Canada Oral Insulin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Europe Oral Insulin Sales Market Share by Country (2020-2031)

Figure 25. Europe Oral Insulin Revenue Market Share by Country (2020-2031)

Figure 26. Germany Oral Insulin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. France Oral Insulin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. U.K. Oral Insulin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. Italy Oral Insulin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Russia Oral Insulin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Asia Pacific Oral Insulin Sales Market Share by Region (2020-2031)

Figure 32. Asia Pacific Oral Insulin Revenue Market Share by Region (2020-2031)

Figure 33. China Oral Insulin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Japan Oral Insulin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. South Korea Oral Insulin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. India Oral Insulin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Australia Oral Insulin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Taiwan Oral Insulin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Indonesia Oral Insulin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Thailand Oral Insulin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Malaysia Oral Insulin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Philippines Oral Insulin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Latin America Oral Insulin Sales Market Share by Country (2020-2031)

Figure 44. Latin America Oral Insulin Revenue Market Share by Country (2020-2031)

Figure 45. Mexico Oral Insulin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Brazil Oral Insulin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Argentina Oral Insulin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Middle East and Africa Oral Insulin Sales Market Share by Country (2020-2031)

Figure 49. Middle East and Africa Oral Insulin Revenue Market Share by Country (2020-2031)

Figure 50. Turkey Oral Insulin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia Oral Insulin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. U.A.E Oral Insulin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Global Sales Market Share of Oral Insulin by Type (2020-2031)

Figure 54. Global Revenue Market Share of Oral Insulin by Type (2020-2031)

Figure 55. Global Oral Insulin Price (US$/Unit) by Type (2020-2031)

Figure 56. Global Sales Market Share of Oral Insulin by Application (2020-2031)

Figure 57. Global Revenue Market Share of Oral Insulin by Application (2020-2031)

Figure 58. Global Oral Insulin Price (US$/Unit) by Application (2020-2031)

Figure 59. Oral Insulin Value Chain

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Oral Medicines for Diabetes Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oral Antidiabetic Drugs Market Insights Forecast to 2030

Global Human Insulin Delivery System Market Insights Forecast to 2030

Global Oral Anti Diabetic Drug Market Insights Forecast to 2030

Type 2 Diabetes Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Automated Insulin Delivery Device Market Research Report 2024

Global Insulin Drugs for Diabetes Market Research Report 2024

Global Human Insulin Drugs And Delivery Devices Market Insights Forecast to 2030

Diabetes Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Home Insulin Delivery Dosing Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Oral Hypoglycemic Medications Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oral Antidiabetic Agents Market Insights Forecast to 2030

Oral Anti diabetes Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oral Antidiabetic OAD Treatment Market Research Report 2024

Global Diabetes Drugs Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031

Global Insulin Management System Market Insights Forecast to 2030

Global Oral Drug Delivery Market Research Report 2025

Global Oral Mucosal Drug Delivery System Market Research Report 2024

Global Non invasive Insulin Market Research Report 2024

RELATED REPORTS

Global Long-Acting HIV-1 Inhibitors Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-19B19893

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Methylphenidate Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-30B3636

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Soliris Intravenous Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-3H1702

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mouth Ulcers Drugs Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-13C3384

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions